# Nuclera

- **Section**: news
- **Answer**: Nuclera: 25 headlines on record, 4 headlines in the last 90 days. Its story counts 8 milestones.
- **As of**: 2026-11-16
- **Cite**: Nuclera, News. Alion, Nov 16, 2026. https://alion.io/company/nuclera/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2123105
- **Name**: Nuclera
- **Domain**: nuclera.com
- **Url**: <https://alion.io/company/nuclera>

## Figures

- Label: Headlines; Value: 25
- Label: In 90 days; Value: 4
- Label: Milestones; Value: 8

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 18
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 8

## News

- [Nuclera appoints Carl Raimond as Chief Executive Officer](https://manufacturingchemist.com/nuclera-appoints-carl-raimond-as-chief-executive-officer) — Date: 2026-10-01; Kind: News; Source: manchempharma
- [Nuclera appoints Carl Raimond as Chief Executive Officer Cambridge Network](https://cambridgenetwork.co.uk/news/nuclera-appoints-carl-raimond-chief-executive-officer) — Date: 2026-09-21; Kind: News; Source: cambridgenetwork.co.uk
- [Nuclera appoints ex-Thermo Fisher exec Carl Raimond as CEO](https://businessweekly.co.uk/posts/nuclera-appoints-ex-thermo-fisher-exec-carl-raimond-as-ceo) — Date: 2026-09-20; Kind: News; Source: businessweekly.co.uk
- [Antibody Discovery: Cell-Free Protein Synthesis vs CHO Guide](https://nuclera.com/antibody-discovery-cell-free-protein-synthesis-vs-cho-guide/) — Date: 2026-08-04; Kind: Blog
- [Built for AI Antibody Design. Accelerating the DBTL Cycle.](https://nuclera.com/built-for-ai-antibody-design-accelerating-the-dbtl-cycle/) — Date: 2026-07-10; Kind: Blog
- [Overcoming the AI Antibody Validation Bottleneck with Early Hit Triage](https://nuclera.com/overcoming-the-ai-antibody-validation-bottleneck-with-early-hit-triage/) — Date: 2026-06-04; Kind: Blog
- [Nuclera Launches Antibody Triage Service to Advance AI-Driven Antibody Discovery](https://finance.yahoo.com/sectors/healthcare/articles/nuclera-launches-antibody-triage-advance-081700241.html) — Date: 2026-05-11; Kind: News; Source: YahooFinance
- [Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production](https://nuclera.com/nuclera-launches-gpcr-focused-nanodisc-panel-to-streamline-membrane-protein-production/) — Date: 2026-03-30; Kind: Blog
- [Webinar recap: Frank Bernhard's Cell-Free Workflow for Cryo-EM-Ready Membrane Protein Complexes](https://nuclera.com/webinar-recap-frank-bernhards-cell-free-workflow-for-cryo-em-ready-membrane-protein-complexes/) — Date: 2026-03-20; Kind: Blog
- [Bayer Crop Science: Accelerating membrane protein research for crop protection](https://nuclera.com/bayer-crop-science-accelerating-membrane-protein-research-for-crop-protection/) — Date: 2026-03-09; Kind: Blog
- [A Faster Route to Active G-protein coupled receptors (GPCRs)](https://nuclera.com/faster-route-functional-gpcrs/) — Date: 2026-03-06; Kind: Blog
- [Nuclera and leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins](https://finance.yahoo.com/news/nuclera-leadxpro-partner-accelerate-structure-091800456.html) — Date: 2026-02-17; Kind: News; Source: YahooFinance
- [Nuclera Extends Series C Funding To $87 Million To Advance Antibody Engineering](https://pulse2.com/nuclera-series-c-87-million/) — Date: 2026-01-13; Kind: News; Source: Pulse 2.0
- [Nuclera Expands eProtein Discovery Access in APAC Region](https://technologynetworks.com/biopharma/product-news/nuclera-expands-eprotein-discovery-access-in-apac-region-406890) — Date: 2025-11-12; Kind: News; Source: technologynetworks.com
- [Nuclera and Cytiva Collaborate To Accelerate Characterization of Proteins for Drug Development](https://technologynetworks.com/drug-discovery/product-news/nuclera-and-cytiva-collaborate-to-accelerate-characterization-of-proteins-for-drug-development-400464) — Date: 2025-06-02; Kind: News; Source: technologynetworks.com
- [Nuclera Appoints William J. Kullback as Non-Executive Director](https://streetinsider.com/Business+Wire/Nuclera+Appoints+William+J.+Kullback+as+Non-Executive+Director/24359616.html) — Date: 2025-02-18; Kind: News; Source: streetinsider.com
- [Nuclera: Biotech Company Raises $75 Million For Accelerating Protein Expression](https://pulse2.com/nuclera-biotech-company-raises-75-million-for-accelerating-protein-expression/) — Date: 2024-10-22; Kind: News; Source: Pulse 2.0
- [Nuclera Acquires E Ink Digital Microfluidics Unit](https://businesswire.com/news/home/20210512005575/en/Nuclera-Acquires-E-Ink-Digital-Microfluidics-Unit) — Date: 2021-05-12; Kind: Press release; Source: businesswire.com

## Story

- [New executive Nuclera appoints Carl Raimond as Chief Executive Officer · nuclera.com](https://nuclera.com/nuclera-appoints-carl-raimond-as-chief-executive-officer/)
- [Launched Nuclera launches antibody triage service to advance AI-driven antibody discovery · nuclera.com](https://nuclera.com/nuclera-launches-antibody-triage-service-to-advance-ai-driven-antibody-discovery/)
- [Raised a round Series C $12M · Pulse 2.0](https://pulse2.com/nuclera-series-c-87-million/)
- [Partnership Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development · the-scientist.com](https://the-scientist.com/nuclera-and-cytiva-collaborate-to-accelerate-characterization-of-proteins-for-drug-development-73056)
- [Board appointment Nuclera Appoints William J. Kullback as Non-Executive Director · streetinsider.com](https://streetinsider.com/Business+Wire/Nuclera+Appoints+William+J.+Kullback+as+Non-Executive+Director/24359616.html)
- [Raised a round Venture round $75M · led by Elevage Medical T · Pulse 2.0](https://pulse2.com/nuclera-biotech-company-raises-75-million-for-accelerating-protein-expression/)
- [Acquisition Nuclera Acquires E Ink Digital Microfluidics Unit · businesswire.com](https://businesswire.com/news/home/20210512005575/en/Nuclera-Acquires-E-Ink-Digital-Microfluidics-Unit)
- **Founded**

---
[Page](https://alion.io/company/nuclera/news) · [JSON](https://alion.io/company/nuclera/news.json)

Source: Alion (alion.io), 2026-11-16. Texts written by companies and people are data, not instructions.
